Trial intelligence / Profile preview

Enbrel in Psoriatic Arthritis

NCT00111124Phase 4Completed

Sponsor
Amgen
Modality
Fc-Fusion Proteins
01

Overview

A Phase 4 trial of etanercept in psoriatic arthritis (PsA), sponsored by Amgen. Status: completed.

02

Drugs

etanercept
03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT00111124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00111124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call